시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
동물 면역진단 시장 규모, 점유율, 성장 분석, 제품별, 기술별, 동물 유형별, 질병 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Veterinary Immunodiagnostics Market Size, Share, Growth Analysis, By Product (CONSUMABLES, INSTRUMENTS), By Technology (CLINICAL BIOCHEMISTRY, Molecular Diagnostics), By Animal Type, By Disease Type, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1630646
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2025년 01월
페이지 정보 : 영문 165 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,395,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,651,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 9,907,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

동물 면역진단 세계 시장 규모는 2023년 27억 달러로 평가되었습니다. 2024년 29억 2,000만 달러에서 2032년에는 54억 4,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 8.1%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

동물 면역진단 시장은 동물 질병의 확산, 질병 특이적 면역진단 검사의 등장, 진단 기술의 발전 등 여러 요인에 의해 강력한 성장세를 보이고 있습니다. 반려동물 사육 수의 급격한 증가와 동물성 식품에 대한 수요 증가는 이러한 성장을 더욱 촉진하고 있습니다. 신흥 경제국은 수의 진단 인프라가 부족한 개발도상국이지만, 성장 기회가 큰 시장으로 떠오르고 있습니다. 현재 진행 중인 코로나19 팬데믹은 인간과 동물 모두에 대한 검사 비율을 높이고 있으며, 검사 시설들은 동물 검사 솔루션의 혁신을 요구하고 있습니다. AVMA와 CDC와 같은 기관은 동물에 대한 일상적인 코로나19 검사를 권장하지 않고 있지만, 보건 당국은 진행 중인 상황에 따라 보건 당국은 진행 상황에 따라 결정을 내릴 수 있으며, 수의사와 보건 당국의 협력의 중요성이 강조되고 있습니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

동물 면역진단 시장 규모 : 제품별

동물 면역진단 시장 규모 : 기술별

동물 면역진단 시장 규모 : 동물 유형별

동물 면역진단 시장 규모 : 질환 유형별

동물 면역진단 시장 규모 : 최종사용자별

동물 면역진단 시장 규모

경쟁 정보

주요 기업 개요

결론과 추천 사항

LSH
영문 목차

영문목차

Global Veterinary Immunodiagnostics Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.92 billion in 2024 to USD 5.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The veterinary immunodiagnostics market is experiencing robust growth driven by several factors, including the increased prevalence of animal diseases, the advent of disease-specific immunodiagnostic tests, and advancements in diagnostic technology. A surge in pet ownership and rising demand for animal-derived food products further fuel this expansion. Emerging economies present significant growth opportunities, despite challenges posed by inadequate veterinary diagnostic infrastructure in developing regions. The ongoing COVID-19 pandemic has heightened testing rates for both humans and animals, compelling laboratories to innovate animal testing solutions. Although organizations like the AVMA and CDC do not endorse routine COVID-19 testing for animals, the decision may be prompted by health officials based on evolving circumstances, underscoring the importance of collaboration between veterinarians and health authorities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Immunodiagnostics Market Segmental Analysis

Global Veterinary Immunodiagnostics Market is segmented by Product, Technology, Animal Type, Disease Type, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Immunodiagnostics and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals and Livestock. Based on Disease Type, the market is segmented into Infectious Disease, Endocrinology, Oncology, Cardiology and Others. Based on End User, the market is segmented into Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-care/ In-house Testing and Veterinary Research Institutes & Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is significantly driven by the potential transmission of serious zoonotic illnesses from animals to humans. At least 30 major diseases, including rabies, leptospirosis, and zoonotic tuberculosis, can spread through livestock and companion animals such as dogs and cats. The increasing prevalence of transboundary diseases, exemplified by foot-and-mouth disease affecting a large portion of livestock globally, further underscores the need for effective immunodiagnostic tools. Additionally, the emergence of zoonotic sources such as those linked to the COVID-19 pandemic highlights the critical role veterinary diagnostics play in safeguarding public health and preventing future outbreaks, ultimately fostering market growth.

Restraints in the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market faces significant restraints due to the rising costs associated with pet care over the last decade. Research indicates that veterinary care represents the second-largest spending category within the pet care industry, with the U.S. alone contributing over $18.11 billion, marking a 6.1% increase from the previous year. High-end veterinary procedures can range from $5,000 to $20,000, while typical diagnostic costs for assessing antimicrobial resistance or infections using advanced techniques like PCR are notably steep. The reliance on expensive materials and cutting-edge technologies for treatments makes pet owners and veterinarians reluctant to invest heavily in diagnostic services.

Market Trends of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is poised for significant growth, driven by the rising prevalence of zoonotic and vector-borne diseases linked to climate change, habitat modification, and evolving social dynamics. As these diseases become more common, there is an increasing need for rapid and precise diagnostic tools, particularly in companion animal medicine in developed countries. This trend is further fueled by a growing preference for advanced diagnostic technologies, such as RT-PCR, over traditional methods. Consequently, veterinary immunodiagnostics will play a critical role in disease management and prevention, positioning itself as a vital segment within the broader veterinary diagnostics market.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Veterinary Immunodiagnostics Market Size by Product & CAGR (2025-2032)

Global Veterinary Immunodiagnostics Market Size by Technology & CAGR (2025-2032)

Global Veterinary Immunodiagnostics Market Size by Animal Type & CAGR (2025-2032)

Global Veterinary Immunodiagnostics Market Size by Disease Type & CAGR (2025-2032)

Global Veterinary Immunodiagnostics Market Size by End User & CAGR (2025-2032)

Global Veterinary Immunodiagnostics Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기